Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2681 |
|
| Actual shortage: | 250 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2422 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
25 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-BUPRENORPHINE/NALOXONE | 2MG 8MG | TABLET | Resolved | 2022-12-01 | 2022-12-22 | 176824 |
| TEVA-ERLOTINIB | 150MG | TABLET | Resolved | 2022-12-01 | 2023-04-28 | 176830 |
| TEVA-LENOLTEC NO. 1 | 8MG 15MG 300MG | TABLET | Resolved | 2022-12-01 | 2023-01-19 | 176833 |
| TEVA-SPIRONOLACTONE/HCTZ | 25MG 25MG | TABLET | Resolved | 2022-12-01 | 2023-02-16 | 176842 |
| TEVA-SUMATRIPTAN DF | 100MG | TABLET | Resolved | 2022-12-01 | 2023-04-28 | 176845 |
| TEVA-DOXAZOSIN | 1MG | TABLET | Resolved | 2022-12-01 | 2023-04-28 | 176857 |
| PORTIA 21 | 0.03MG 0.15MG | TABLET | Resolved | 2022-12-08 | 2022-12-22 | 177502 |
| PORTIA 28 | 0.03MG 0.15MG | TABLET | Resolved | 2022-12-08 | 2022-12-22 | 177505 |
| TEVA-ATORVASTATIN | 20MG | TABLET | Resolved | 2022-12-08 | 2023-01-12 | 177508 |
| TEVA-ATORVASTATIN | 20MG | TABLET | Resolved | 2022-12-08 | 2023-01-12 | 177511 |
| TEVA-ATORVASTATIN | 40MG | TABLET | Resolved | 2022-12-08 | 2023-02-02 | 177514 |
| TEVA-ATORVASTATIN | 40MG | TABLET | Resolved | 2022-12-08 | 2023-01-12 | 177517 |
| TEVA-CLONIDINE | 0.025MG | TABLET | Resolved | 2022-12-08 | 2023-01-26 | 177520 |
| TEVA-LORAZEPAM | 0.5MG | TABLET | Resolved | 2022-12-08 | 2023-04-28 | 177523 |
| TEVA-LORAZEPAM | 2MG | TABLET | Resolved | 2022-12-08 | 2023-06-09 | 177526 |
| TEVA-NAPROXEN | 500MG | TABLET | Resolved | 2022-12-08 | 2023-01-19 | 177529 |
| TEVA-ZOPICLONE | 7.5MG | TABLET | Resolved | 2022-12-08 | 2022-12-15 | 177532 |
| ZADITEN | 1MG | TABLET | Resolved | 2022-12-08 | 2023-04-15 | 177535 |
| ACT AMLODIPINE | 5MG | TABLET | Resolved | 2022-12-15 | 2023-02-16 | 178518 |
| ACT LEVOFLOXACIN | 250MG | TABLET | Resolved | 2022-12-15 | 2023-04-28 | 178521 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT NABILONE | 1MG | CAPSULE | Discontinued | 2019-10-31 | 2019-11-01 | 97581 |
| NOVAMOXIN | 250MG | CAPSULE | Discontinued | 2020-01-24 | 2020-01-24 | 104289 |
| TEVA-QUININE | 300MG | CAPSULE | Discontinued | 2020-01-24 | 2020-01-24 | 104294 |
| TEVA-TRANDOLAPRIL | 0.5MG | CAPSULE | Discontinued | 2020-07-10 | 2020-07-10 | 120021 |
| TEVA-TRANDOLAPRIL | 1MG | CAPSULE | Discontinued | 2020-07-10 | 2020-07-10 | 120024 |
| TEVA-TRANDOLAPRIL | 2MG | CAPSULE | Discontinued | 2020-07-10 | 2020-07-10 | 120027 |
| TEVA-TRANDOLAPRIL | 4MG | CAPSULE | Discontinued | 2020-07-10 | 2020-07-10 | 120030 |
| TEVA-PREGABALIN | 75MG | CAPSULE | Discontinued | 2020-07-10 | 2020-07-10 | 120033 |
| ACT CELECOXIB | 100MG | CAPSULE | To be discontinued | 2020-09-03 | 2020-09-03 | 123648 |
| ACT CELECOXIB | 200MG | CAPSULE | To be discontinued | 2020-09-03 | 2020-09-03 | 123651 |
| TEVA-QUININE | 200MG | CAPSULE | Discontinued | 2020-10-08 | 2020-10-09 | 125976 |
| TEVA-CEPHALEXIN | 500MG | CAPSULE | Discontinued | 2020-10-08 | 2020-10-09 | 125979 |
| ACT NABILONE | 0.5MG | CAPSULE | Discontinued | 2020-10-15 | 2020-10-15 | 126452 |
| ACT CELECOXIB | 200MG | CAPSULE | Discontinued | 2021-02-12 | 2021-02-12 | 133874 |
| ACT CELECOXIB | 100MG | CAPSULE | Discontinued | 2021-02-12 | 2021-02-12 | 133880 |
| ACT NABILONE | 0.5MG | CAPSULE | Discontinued | 2021-09-23 | 2021-09-23 | 146066 |
| TEVA-DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Discontinued | 2020-06-11 | 2020-06-11 | 117491 |
| TEVA-DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | Discontinued | 2020-06-11 | 2020-06-11 | 117494 |
| ACT VENLAFAXINE XR | 75.0MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65292 |
| ACT VENLAFAXINE XR | 75.0MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65295 |